August 24, 2022 Meeting of the Iowa Board of Pharmacy

Meeting Location: The meeting will be held via Zoom and in-person at the Board of Pharmacy office.  To access the meeting, see details below:

Join Zoom Meeting:
https://zoom.us/join
Meeting ID: 863 2803 8223
Passcode: k0JM8r
One tap mobile
312-626-6799, 86328038223#, *648734# US (Chicago)

Board Meeting Sign In Sheet – Pharmacists and technicians may obtain 1 hour of law CE for their attendance

9:00 a.m.         Call to Order & Announcements

Public Comment Period—anyone who has submitted material for the agenda will be given an opportunity to address the Board during the particular agenda item.  A member of the public wishing to address the Board regarding a particular agenda item should raise a hand during that agenda item to be recognized. During the initial public comment period, members of the public will have the opportunity to address the Board regarding any items not on the agenda, or any agenda item if the person is unable to be present for the discussion of the particular agenda item. Acknowledgment and an opportunity to speak will be limited to 5 minutes per person, with additional time allowed at the discretion of the chairperson.

Approval of Minutes

1. June 28, 2022 Open Session Minutes

AlixaRx’s Innovative Pharmacy Pilot Project Quarterly Report

Requests

1. Request pursuant to 657 IAC 2.12(6)“a” to receive credit for health-related graduate studies - Meghal Patel, Pharmacist License 23907, Coralville
2. Request to waive 657 IAC 10.5(4) to allow for refund of registration and associated fees - Dahlia Saha, CSA registration 1251646 (canceled), Davenport
3. Request to waive 657 IAC 4.6(3)“c” to delay the expiration of intern registration for one year - Rawiah Al-Rawi, Pharmacist-intern registration 8083, Iowa City
4. Request to waive 657 IAC 20.4 and 8.5(11) requiring compliance with USP 800 - MercyOne Medical Center, Pharmacy license 321, Des Moines
5. Request to waive 657 IAC 21.10(3)“b” requiring pharmacist final verification on prescriptions filled utilizing an automated medication dispensing system - Walgreen Co, License “Pending”, Bolingbrook, IL

Reports & Informational Items

1. Executive Director’s Report
2. Meetings and Travel
3. Legal Update
4. Prescription Monitoring Program (PMP) Update
5. Board-Sponsored Medication Disposal Update
6. Iowa Monitoring Program for Pharmacy Professionals (IMP3) Update
7. Compliance Report
8. Well-being Index for Pharmacy Personnel Report

Review of Proposed Edits to the Board’s Statewide Protocols and Vote on Approval

1. Point-of-Care Test and Treat - Influenza
2. Point-of-Care Test and Treat - Strep A

Rules and Legislation

1. Proposed for adoption and filing to amend Chapter 10, “Controlled Substances,” to temporarily amend Iowa Code to add seven schedule I substances and one schedule IV substance in response to similar action taken by the federal DEA (ARC 6334C)
2. Proposed for adoption and filing to amend Chapter 20, “Compounding Practices,” to require documentation of all ingredient sources, lot numbers, and expiration dates and the steps involved in the compounding process for all nonsterile and sterile compounded preparations (ARC 6333C)
3. Proposed for notice of intended action to amend Chapter 10, “Controlled Substances,” to temporarily amend Iowa Code to add one schedule I substance in response to similar action taken by the federal DEA
4. Proposed for notice of intended action to amend Chapter 37, “Iowa Prescription Monitoring Program,” establishing council membership information for the PMP Advisory Council and to clarify that only overdose-reversal opioid antagonists are required to be reported to the PMP
5. Draft pre-file Controlled Substances Act bill

Motion to go into closed session pursuant to Iowa Code section 21.5(1)(a), to review or discuss records which are required or authorized by state or federal law to be kept confidential; pursuant to Iowa Code section 21.5(1)(d), to discuss whether to initiate licensee disciplinary investigations or proceedings; and pursuant to Iowa Code section 21.5(1)(f), to discuss the decision to be rendered in a contested case conducted according to the provisions of Iowa Code chapter 17A.

1. Review of Closed Session Minutes – 21.5(1)(a)
   1. June 28, 2022 Closed Session Minutes
2. Complaints and Investigative Reports – 21.5(1)(d)
3. Settlement Agreements and Final Orders – 21.5(1)(f)
   1. 2020-0175 Walgreens 07967, License 1257, Clive
   2. 2020-0176 Walgreens 05060, License 1086, Clive
   3. 2020-0177 Walgreens 07454, License 197, Ankeny
   4. 2020-0178 & 2021-0236 Walgreens 05721, License 355, Des Moines
   5. 2020-0179 Walgreens 359, License 778, Des Moines
   6. 2020-0180 Walgreens 07455, License 1210, Waterloo
   7. 2020-0181 Walgreens 04714, License 459, Des Moines
   8. 2021-0190 & 2022-0010 Walgreens 05941, License 1128, Mason City
4. Combined Statements of Charges, Settlement Agreements and Final Orders – 21.5(1)(d) & (f)

Return to Open Session

Votes on any closed session agenda items requiring final action

Adjournment